高剂量肌酸疗法治疗亨廷顿病：一项为期2年的临床和磁共振波谱研究。 - Suppr

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

作者信息

Tabrizi S J, Blamire A M, Manners D N, Rajagopalan B, Styles P, Schapira A H V, Warner T T

机构信息

Department of Neurodegenerative Disease, Institute of Neurology, and National Hospital for Neurology and Neurosurgery, London, UK.

出版信息

Neurology. 2005 May 10;64(9):1655-6. doi: 10.1212/01.WNL.0000160388.96242.77.

DOI:10.1212/01.WNL.0000160388.96242.77

PMID:15883340

Abstract

摘要

相似文献

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

Neurology. 2005 May 10;64(9):1655-6. doi: 10.1212/01.WNL.0000160388.96242.77.

Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.

Neurology. 2003 Jul 8;61(1):141-2. doi: 10.1212/01.wnl.0000070186.97463.a7.

Creatine supplementation lowers brain glutamate levels in Huntington's disease.

J Neurol. 2005 Jan;252(1):36-41. doi: 10.1007/s00415-005-0595-4.

1H magnetic resonance spectroscopy in preclinical Huntington disease.

Brain Res. 2007 Sep 7;1168:67-71. doi: 10.1016/j.brainres.2007.05.082. Epub 2007 Jul 17.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

J Psychiatr Res. 2007 Oct;41(8):625-34. doi: 10.1016/j.jpsychires.2006.07.002. Epub 2006 Sep 1.

Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain.

J Neurosci Methods. 2008 Jul 30;172(2):215-9. doi: 10.1016/j.jneumeth.2008.04.028. Epub 2008 May 8.

Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease.

Neurochem Int. 2006 Jan;48(2):93-9. doi: 10.1016/j.neuint.2005.09.002. Epub 2005 Nov 14.

MR imaging and spectroscopy in juvenile Huntington disease.

Pediatr Radiol. 2004 Aug;34(8):640-3. doi: 10.1007/s00247-004-1159-y. Epub 2004 Mar 23.

MR-spectroscopic findings in juvenile-onset Huntington's disease.

Mov Disord. 2008 Oct 15;23(13):1931-5. doi: 10.1002/mds.22245.

Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children.

Neurology. 2005 May 10;64(9):1644-7. doi: 10.1212/01.WNL.0000160391.58004.D4.

引用本文的文献

Evidence-Based Review on Symptomatic Management of Huntington's Disease.

J Mov Disord. 2024 Oct;17(4):369-386. doi: 10.14802/jmd.24140. Epub 2024 Aug 9.

An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid.

Molecules. 2024 Feb 8;29(4):776. doi: 10.3390/molecules29040776.

The potential role of creatine supplementation in neurodegenerative diseases.

Phys Act Nutr. 2023 Dec;27(4):48-54. doi: 10.20463/pan.2023.0037. Epub 2023 Dec 31.

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.

Antioxidants (Basel). 2023 Feb 24;12(3):571. doi: 10.3390/antiox12030571.

Effects of Creatine Supplementation on Brain Function and Health.

Nutrients. 2022 Feb 22;14(5):921. doi: 10.3390/nu14050921.

Improvement of Oxidative Stress and Mitochondrial Dysfunction by -Caryophyllene: A Focus on the Nervous System.

Antioxidants (Basel). 2021 Apr 1;10(4):546. doi: 10.3390/antiox10040546.

A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington's Disease.

Tremor Other Hyperkinet Mov (N Y). 2019 Aug 26;9. doi: 10.7916/tohm.v0.678. eCollection 2019.

Creatine as a Neuroprotector: an Actor that Can Play Many Parts.

Neurotox Res. 2019 Aug;36(2):411-423. doi: 10.1007/s12640-019-00053-7. Epub 2019 May 8.

Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review.

Neurotox Res. 2019 Apr;35(3):739-774. doi: 10.1007/s12640-018-9989-9. Epub 2019 Jan 11.

The CREST-E study of creatine for Huntington disease: A randomized controlled trial.

Neurology. 2017 Aug 8;89(6):594-601. doi: 10.1212/WNL.0000000000004209. Epub 2017 Jul 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

Neurology. 2005 May 10;64(9):1655-6. doi: 10.1212/01.WNL.0000160388.96242.77.

Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.

Neurology. 2003 Jul 8;61(1):141-2. doi: 10.1212/01.wnl.0000070186.97463.a7.

Creatine supplementation lowers brain glutamate levels in Huntington's disease.

J Neurol. 2005 Jan;252(1):36-41. doi: 10.1007/s00415-005-0595-4.

1H magnetic resonance spectroscopy in preclinical Huntington disease.

Brain Res. 2007 Sep 7;1168:67-71. doi: 10.1016/j.brainres.2007.05.082. Epub 2007 Jul 17.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

J Psychiatr Res. 2007 Oct;41(8):625-34. doi: 10.1016/j.jpsychires.2006.07.002. Epub 2006 Sep 1.

Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain.

J Neurosci Methods. 2008 Jul 30;172(2):215-9. doi: 10.1016/j.jneumeth.2008.04.028. Epub 2008 May 8.

Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease.

Neurochem Int. 2006 Jan;48(2):93-9. doi: 10.1016/j.neuint.2005.09.002. Epub 2005 Nov 14.

MR imaging and spectroscopy in juvenile Huntington disease.

Pediatr Radiol. 2004 Aug;34(8):640-3. doi: 10.1007/s00247-004-1159-y. Epub 2004 Mar 23.

MR-spectroscopic findings in juvenile-onset Huntington's disease.

Mov Disord. 2008 Oct 15;23(13):1931-5. doi: 10.1002/mds.22245.

Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children.

Neurology. 2005 May 10;64(9):1644-7. doi: 10.1212/01.WNL.0000160391.58004.D4.

引用本文的文献

Evidence-Based Review on Symptomatic Management of Huntington's Disease.

J Mov Disord. 2024 Oct;17(4):369-386. doi: 10.14802/jmd.24140. Epub 2024 Aug 9.

An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid.

Molecules. 2024 Feb 8;29(4):776. doi: 10.3390/molecules29040776.

The potential role of creatine supplementation in neurodegenerative diseases.

Phys Act Nutr. 2023 Dec;27(4):48-54. doi: 10.20463/pan.2023.0037. Epub 2023 Dec 31.

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.

Antioxidants (Basel). 2023 Feb 24;12(3):571. doi: 10.3390/antiox12030571.

Effects of Creatine Supplementation on Brain Function and Health.

Nutrients. 2022 Feb 22;14(5):921. doi: 10.3390/nu14050921.

Improvement of Oxidative Stress and Mitochondrial Dysfunction by -Caryophyllene: A Focus on the Nervous System.

Antioxidants (Basel). 2021 Apr 1;10(4):546. doi: 10.3390/antiox10040546.

A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington's Disease.

Tremor Other Hyperkinet Mov (N Y). 2019 Aug 26;9. doi: 10.7916/tohm.v0.678. eCollection 2019.

Creatine as a Neuroprotector: an Actor that Can Play Many Parts.

Neurotox Res. 2019 Aug;36(2):411-423. doi: 10.1007/s12640-019-00053-7. Epub 2019 May 8.

Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review.

Neurotox Res. 2019 Apr;35(3):739-774. doi: 10.1007/s12640-018-9989-9. Epub 2019 Jan 11.

The CREST-E study of creatine for Huntington disease: A randomized controlled trial.

Neurology. 2017 Aug 8;89(6):594-601. doi: 10.1212/WNL.0000000000004209. Epub 2017 Jul 12.

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

作者信息

Tabrizi S J, Blamire A M, Manners D N, Rajagopalan B, Styles P, Schapira A H V, Warner T T

机构信息

Department of Neurodegenerative Disease, Institute of Neurology, and National Hospital for Neurology and Neurosurgery, London, UK.

出版信息

Neurology. 2005 May 10;64(9):1655-6. doi: 10.1212/01.WNL.0000160388.96242.77.

DOI:10.1212/01.WNL.0000160388.96242.77

PMID:15883340

Abstract

摘要

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

作者信息

机构信息

出版信息